Stepan Company
General ticker "SCL" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $1.3B (TTM average)
Stepan Company follows the US Stock Market performance with the rate: 5.8%.
Estimated limits based on current volatility of 1.3%: low 45.25$, high 46.41$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-08-29, amount 0.39$ (Y3.47%)
- Total employees count: 2396 (+0.3%) as of 2024
- US accounted for 55.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Raw material cost volatility, Supply chain disruptions, Execution risks, Acquisition/divestiture risks
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [49.82$, 80.24$]
- 2025-12-31 to 2026-12-31 estimated range: [51.91$, 82.25$]
Financial Metrics affecting the SCL estimates:
- Negative: with PPE of 30.3 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 3.23
- Positive: 6.82 < Operating cash flow per share per price, % of 10.63
- Positive: -14.38 < Investing cash flow per share per price, % of -7.67
- Positive: 0 < Industry earnings per price (median), % of 2.23
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.14
- Positive: 41.86 < Shareholder equity ratio, % of 50.76 <= 63.39
- Negative: Inventory ratio change, % of 1.45 > 0.84
- Positive: 0 < Industry operating cash flow per share per price (median), % of 4.95
Short-term SCL quotes
Long-term SCL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,773.27MM | $2,325.77MM | $2,180.27MM |
| Operating Expenses | $2,565.93MM | $2,267.16MM | $2,109.79MM |
| Operating Income | $207.34MM | $58.61MM | $70.48MM |
| Non-Operating Income | $-18.63MM | $-10.22MM | $-10.04MM |
| Interest Expense | $9.81MM | $12.10MM | $14.18MM |
| R&D Expense | $66.63MM | $59.04MM | $55.67MM |
| Income(Loss) | $188.70MM | $48.39MM | $60.44MM |
| Taxes | $41.55MM | $8.19MM | $10.07MM |
| Profit(Loss)* | $147.15MM | $40.20MM | $50.37MM |
| Stockholders Equity | $1,166.07MM | $1,216.49MM | $1,169.93MM |
| Inventory | $402.53MM | $265.56MM | $288.72MM |
| Assets | $2,433.17MM | $2,363.35MM | $2,304.65MM |
| Operating Cash Flow | $160.76MM | $174.88MM | $162.05MM |
| Capital expenditure | $301.55MM | $260.33MM | $122.78MM |
| Investing Cash Flow | $-308.09MM | $-258.67MM | $-116.94MM |
| Financing Cash Flow | $166.21MM | $33.28MM | $-64.52MM |
| Earnings Per Share** | $6.46 | $1.77 | $2.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.